Drug Trials Snapshots: ENJAYMO

[FDA]

ENJAYMO is a prescription drug that decreases the need for red blood cell (RBC) transfusion due to hemolysis (red blood cell destruction) in adults with cold agglutinin disease (CAD).


Baca selengkapnya di : http://www.fda.gov...